Ignite Creation Date:
2024-05-06 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06016920
Status:
RECRUITING
Last Update Posted:
2024-04-11
First Post:
2023-08-24
Brief Title:
Safety and Efficacy of VB1016 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma
Sponsor:
Nykode Therapeutics ASA
Organization:
Nykode Therapeutics ASA
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-19
Start Date Type:
ACTUAL
Primary Completion Date:
2027-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-24
First Submit QC Date:
August 24 2023
Study First Post Date:
2023-08-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-05
Last Update Post Date:
2024-04-11
Last Update Post Date Type:
ACTUAL